Stimulant maintenance: definition, how it works, and effectivity
Stimulant maintenance refers to the supervised, long-term use of prescribed stimulant medications to manage cravings and withdrawal symptoms in individuals with stimulant use disorder.
Stimulant maintenance works by giving people who abuse stimulants carefully controlled prescription forms of comparable drugs. Under medical supervision, patients receive controlled pharmaceuticals rather than searching for illicit drugs of unknown purity.
Stimulant maintenance has demonstrated efficacy in helping people cut back on taking illegal stimulants like cocaine and amphetamines. Among the nations to have applied the approach with positive outcomes are England, Australia, United States, and Canada.
What is stimulant maintenance?
Stimulant maintenance is a medical approach to helping people with stimulant use disorders, such as amphetamine and cocaine addiction. Prescription regulated doses of pharmacological stimulants—such as methylphenidate or dextroamphetamine—are recommended to lower cravings, decrease withdrawal symptoms, and stabilize behavior.
Aiming not necessarily for instantaneous abstinence but rather for safer and more controllable usage, the strategy falls under the broader category of addiction harm reduction. For people with cocaine addiction, stimulant maintenance reduces the urge to seek out street cocaine by satisfying neurochemical imbalances in a safer, regulated manner.
In cases of amphetamine addiction, prescribed alternatives help lessen the psychological and physical impact of stopping high-dose recreational amphetamines abruptly. Medical professionals tailor the plan based on individual needs, considering factors like dosage, duration, and the presence of co-occurring mental health disorders.
What is the goal of stimulant maintenance?
The goal of stimulant maintenance is to lessen damage by reducing the likelihood of overdose through the provision of safer, legal alternatives to uncontrolled street substances. Stimulant maintenance provides a controlled environment where the use of prescribed stimulants replaces unpredictable street drug use.
One of the key benefits includes minimizing the highs and crashes often associated with illicit stimulant use. Individuals gradually regain functionality in both personal responsibilities and professional roles without the chaos of compulsive drug-seeking behavior.
Treatment frequently results in a reduction of drug withdrawal symptoms, enabling patients to continue attending therapy and more successfully seek long-term recovery. As a way to maintain therapeutic stability, healthcare professionals work in tandem with patients to monitor progress and make appropriate adjustments.
How does stimulant maintenance work?
Stimulant maintenance works by providing individuals who misuse stimulants with carefully regulated prescription versions of similar substances. Instead of seeking out illegal drugs with unpredictable purity, patients receive controlled medications through medical supervision.
Aiming to reduce negative consumption patterns, health professionals offer a safer option by using pharmaceutical-grade stimulants such as Dexedrine. Through the use of steady and established dosages, stimulant maintenance aids in stabilization of brain activity and better control of cravings.
How effective is stimulant maintenance?
Stimulant maintenance has demonstrated efficacy in assisting persons in decreasing their use of illegal stimulants such as amphetamines and cocaine. England, Australia, United States, and Canada are among the countries to have used the strategy and had favorable results.
A 1998 study by Ben Charnaud and Vanessa Griffiths, titled “Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: a comparison” found oral dexamphetamine substitute prescription for primary amphetamine abusers was just as successful in lowering intravenous drug usage as oral methadone for primary opiate abusers, with 70% and 67% of the corresponding groups stopping injections at discharge.
A 2003 trial by Shearer et al., titled “Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence” monitored 30 cocaine injectors, 16 of whom were administered dexamphetamine and 14 were administered a placebo.
After 14 weeks, the dexamphetamine group experienced a decrease in the percentage of cocaine-positive urine tests from 94% to 56%, while the placebo group did not exhibit any change.
John Grabowski, a former psychiatry professor at the University of Minnesota, has spearheaded research into stimulant maintenance treatment in the United States.
In the 2004 study titled “Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence” Grabowski and his co-authors revealed agonist-like or replacement pharmacotherapy shows great potential for the treatment of stimulant addiction and dependence, with evidence from both clinical trials and preclinical studies corroborated.
Preclinical evidence points to the most consistent efficacy for dopamine-selective reuptake inhibitors (e.g., GBR 12909) and monoamine releasers (e.g., dextroamphetamine). Clinical trials have shown dextroamphetamine, modafinil, and oral cocaine all reduce drug use, cravings, and associated harms.
While there are certain obstacles to overcome, such as low-quality studies, resistance to agonist methods, and certain side effects (such as psychosis or diversion), the dangers associated with sustained agonist regimens are probably less than those of ongoing illegal use.
A 2021 case report by Palis et al., titled “Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report” demonstrated the prescription of dextroamphetamine resulted in a substantial decrease in crack cocaine use in a patient with long-standing stimulant use disorders, from 10–15 rocks daily to 1–2 rocks twice a week. Although not entirely eradicated, the patient observed diminished cravings and attributed the decrease to dextroamphetamine.
Why is stimulant maintenance controversial?
Stimulant maintenance is controversial because it involves prescribing substances similar to the very drugs individuals are trying to stop using. Critics claim prescribing stimulants to sufferers of stimulant addiction increases the risk of continued dependence while failing to encourage genuine recovery.
Opponents worry about the potential for diversion, where prescribed stimulants are sold or shared illegally. Others question whether stimulant maintenance truly addresses the underlying psychological and social causes of addiction.
Despite success stories, a number of elements help explain why stimulant maintenance treatment was not first investigated more closely. For example, high amphetamine doses compromise health by causing psychosis, brain damage, stroke, and heart attack.
Notwithstanding controversy, supporters of stimulant maintenance point out its potential for harm reduction, emphasizing stability and safety for patients who have not found success with abstinence-only treatments.
